Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 1993 May:28 Suppl 5:109-14.
doi: 10.1007/BF02989219.

Autoimmunity during alpha-interferon therapy for chronic hepatitis C

M Yoshikawa  1 , T Sakamoto, A Mitoro, T Mochi, H Tsujii, M Koizumi, H Yoshiji, Y Sakaguchi, H Fukui, H Nakano, et al.
Affiliations
Case Reports

Autoimmunity during alpha-interferon therapy for chronic hepatitis C

M Yoshikawa et al. Gastroenterol Jpn. 1993 May.

Abstract

One hundred twenty-five patients with chronic hepatitis C were treated with natural IFN alpha or recombinant IFN alpha-2a, daily doses of 3 MU or 9 MU, respectively. IFNs were given 6 times a week for the first 2 weeks followed by thrice weekly administration for 12 weeks or more. ANA, TMA, AMA and anti-DNA antibody newly developed in 8, 1, 2 and 1 patient, respectively. Furthermore, we encountered some cases in which underlying autoimmune disorders were thought to be exacerbated by IFNs. It is important to pay sufficient attention to the development of autoimmune diseases in IFN therapy for chronic hepatitis C.

PubMed Disclaimer

References

    1. Gastroenterology. 1992 Apr;102(4 Pt 1):1406-8 - PubMed
    1. Gastroenterology. 1992 Jun;102(6):2155-60 - PubMed
    1. Ann Intern Med. 1991 Nov 1;115(9):700-4 - PubMed
    1. J Med Virol. 1991 Aug;34(4):223-6 - PubMed
    1. Lancet. 1991 May 18;337(8751):1183-7 - PubMed

Publication types

LinkOut - more resources